Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gluten and Intestinal Barrier in NCGS and IBS-D
NCT02098057Completed
- Sponsor
- Mayo Clinic
- Start
- Apr 2014
- Primary completion
- Sep 2016
- Countries
- 1
01
Overview
Randomised, double-blind trial in non-celiac gluten sensitivity (NCGS) and irritable bowel syndrome (IBS), sponsored by Mayo Clinic. Primary endpoint: Change in permeability of the small intestine at 4 weeks. Started Apr 2014; status: completed.
02
Conditions
non-celiac gluten sensitivity (NCGS)irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT02098057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02098057.